This post is from a suggested group
Specialized Blood Component Therapy: Analyzing the Service Demand in the US Apheresis Service Market
The US Apheresis Service Market focuses on the specialized medical procedure where blood is removed from a patient or donor, separated into components, and a specific component (e.g., plasma, platelets, or certain white blood cells) is selectively retained or removed before the remaining blood components are returned to the patient or donor. This market is driven by both therapeutic and donor applications. On the therapeutic side, it is a crucial intervention for treating a growing number of conditions, including autoimmune diseases (e.g., myasthenia gravis, Guillain-Barré syndrome, using plasma exchange or plasmapheresis), hematologic disorders (e.g., sickle cell disease, using erythrocytapheresis), and increasingly, cancer-related therapies (e.g., collecting cells for CAR T-cell therapy via leukapheresis). The demand for service delivery is a key market driver, as the procedure requires specialized equipment and highly trained personnel, often centralized in hospitals,…
I would rather have an old, gaffe prone man then someone who thinks only of himself and makes up lies like be is breathing.